Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
02/29/2012 | EP2421554A1 Tissue kallikrein for the treatment of huntington's disease |
02/29/2012 | EP2421553A1 Tissue kallikrein for the treatment of schizophrenia and bipolar disorder |
02/29/2012 | EP2421535A1 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors |
02/29/2012 | EP2421534A1 Liquid formulations of salts of 1-ý2-(2,4-dimethylphenylsulfanyl)phenyl¨piperazine |
02/29/2012 | EP2421523A1 Method of treating or preventing a convulsive disorder in a patient in need thereof |
02/29/2012 | EP2421367A1 Allantoin administration for the treatment of neurodegenerative disease and neurotrauma |
02/29/2012 | EP2421366A1 Heterocyclic fused cinnoline m1 receptor positive allosteric modulators |
02/29/2012 | EP2328866B1 3',6-substituted indirubins and their biological applications |
02/29/2012 | EP1951718B1 4-oxadiazolyl-piperidine compounds and use thereof |
02/29/2012 | EP1909804B1 Glucosamine and derivatives thereof useful as transglutaminase inhibitors in the treatment of a nervous system disorder |
02/29/2012 | EP1827461B1 Cladribine regimen for treating multiple sclerosis |
02/29/2012 | EP1669350B1 Piperidine derivatives |
02/29/2012 | EP1572725B1 Chi-conotoxin peptides having a n-terminal pyroglutamic acid |
02/29/2012 | CN102365294A Dipeptide mimetics of ngf and bdnf neurotrophins |
02/29/2012 | CN102365280A New adenosine receptor ligands and uses thereof |
02/29/2012 | CN102365279A Hydroxy-methyl isoxazole derivatives as gaba a modulators |
02/29/2012 | CN102365269A Novel therapeutic agent for cognitive impairment |
02/29/2012 | CN102365265A Indane derivatives |
02/29/2012 | CN102365087A Methods for improving cognitive function and decreasing heart rate |
02/29/2012 | CN102363767A Neuron-like cells obtained by processing neural stem cells by use of saikoside alpha, development of kit thereof and composition for treating nervous system diseases |
02/29/2012 | CN102363035A Medicinal liquor for treating aphonia due to stroke |
02/29/2012 | CN102363032A Traditional Chinese medicine for treating headache |
02/29/2012 | CN102363022A Chinese medicine for treating postpartum anemic fainting |
02/29/2012 | CN102363016A Traditional Chinese medicine composite dripping core pills and preparation method thereof |
02/29/2012 | CN102362945A Preparation method of four-season common cold capsules |
02/29/2012 | CN102362944A Traditional Chinese medicine for treating migraine |
02/29/2012 | CN102362925A Chinese medicine for treating insomnia |
02/29/2012 | CN102362908A Medicinal composition for treating kidney-yang deficiency and preparation method thereof |
02/29/2012 | CN102362907A Traditional Chinese medicine for treating wind-cold headache |
02/29/2012 | CN102362904A Chinese medicinal preparation for tonifying spleen and soothing nerves and production method thereof |
02/29/2012 | CN102362893A Ganoderma lucidum-chrysanthemum capsule for improving sleep and preparation method thereof |
02/29/2012 | CN102362867A Treating seizures using ice inhibitors |
02/29/2012 | CN102362755A Medicinal pillow with effect of benefiting intelligence |
02/29/2012 | CN102078555B Traditional Chinese medicine for treating migraine |
02/29/2012 | CN101982170B Amide compound and application thereof in preparing monoamine oxidase inhibitor |
02/29/2012 | CN101954006B Chinese medicament for treating insomnia |
02/29/2012 | CN101926950B Brain-invigorating traditional Chinese medicine composite and preparation method and detection method thereof |
02/29/2012 | CN101781246B Improved method for synthesizing Aripiprazole |
02/29/2012 | CN101778632B Remedy or preventive for integration dysfunction syndrome |
02/29/2012 | CN101723954B Technique for preparing olanzapine |
02/29/2012 | CN101711857B Film coating agent for treating whitevein and preparation method thereof |
02/29/2012 | CN101703755B Gel for treating white-plus disease and preparation method thereof |
02/29/2012 | CN101700385B Pharmaceutical composition medicinal liquor or tincture for curing white vein disease and preparation method thereof |
02/29/2012 | CN101698096B Plaster for treating white vein diseases and preparation method thereof |
02/29/2012 | CN101669992B Distinguishing method and measuring method of perilla leaf oil |
02/29/2012 | CN101669549B Method for preparing milk tea |
02/29/2012 | CN101590152B Preparation method of Bawei Chenxiang capsule |
02/29/2012 | CN101574347B Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing |
02/29/2012 | CN101560230B Helicid extraction method |
02/29/2012 | CN101530500B Application of blood-nourishing and brain-refreshing granules in preparing medicine for reducing cerebral infarction |
02/29/2012 | CN101518351B Weak alkali plant alcohol intoxication-alleviating beverage and method for preparing same |
02/29/2012 | CN101516886B Thiophene pyrazolopyrimidine compounds |
02/29/2012 | CN101411753B Use of broomrape glycosides in preparing medicine for treating senile dementia |
02/29/2012 | CN101400659B Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
02/29/2012 | CN101288653B Methylphenidate hydrochloride sustained-release floating micropill in stomach and its preparation method |
02/29/2012 | CN101204421B Traditional Chinese traditional medicine composition for dispelling wind, activating blood circulation, stopping pain and preparation method thereof |
02/28/2012 | US8124640 non-film-coated tablets comprising a mixture of 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole hydrochloride, microcrystalline cellulose, lubricants, colloidal silica and lactose, having stability |
02/28/2012 | US8124638 Tricyclic compounds useful as angiotensin II agonists |
02/28/2012 | US8124614 Steroidal compounds for inhibiting steroid sulphatase |
02/28/2012 | US8124608 Mixture of disaccharides, polysaccharides and solvent |
02/28/2012 | US8124600 5-HT3 receptor modulators, methods of making, and use thereof |
02/28/2012 | US8124585 Composition for relieving discomfort |
02/28/2012 | US8124134 Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from Acacia |
02/28/2012 | US8124122 Female hormone-containing patch |
02/28/2012 | US8124081 Using amyloid A specific immunoglobulin for use in prevention and treatment of infection, nervous system, cell proliferative and inflammatory disorders |
02/28/2012 | US8124057 Propellant-based nanoparticulate dry powder aerosols and method of making |
02/28/2012 | CA2514220C Ep4 receptor antagonists |
02/28/2012 | CA2505139C Oromucosal formulation and process for preparing the same |
02/28/2012 | CA2501335C Compounds capable of activating cholinergic receptors |
02/28/2012 | CA2392202C Constructs for delivery of therapeutic agents to neuronal cells |
02/28/2012 | CA2333951C Method for treating neurodegenerative disorders |
02/23/2012 | WO2012024630A1 Treatment of cognitive disorders associated with abnormal dendritic spines using pkc activators |
02/23/2012 | WO2012024615A1 Nicotinic receptor compounds |
02/23/2012 | WO2012024452A2 Modified relaxin polypeptides and their uses |
02/23/2012 | WO2012024397A2 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
02/23/2012 | WO2012024293A2 Medical foods for the treatment of developmentally-based neuropsychiatric disorders via modulation of brain glycine and glutathione pathways |
02/23/2012 | WO2012024223A2 Combination therapy with anti-cd74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases |
02/23/2012 | WO2012024187A1 Amyloid-beta binding proteins |
02/23/2012 | WO2012024161A1 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists |
02/23/2012 | WO2012023623A2 Agent for treatment of hunter syndrome |
02/23/2012 | WO2012023597A1 Composition containing tetracyclic compound |
02/23/2012 | WO2012023254A1 Novel anti-inflammatory metabolite derived from omega-3-type fatty acid |
02/23/2012 | WO2012022919A2 Nalbuphine-based formulations and uses thereof |
02/23/2012 | WO2012022794A1 Pyridazin derivatives as antagonists of the bradykinin b1 receptor |
02/23/2012 | WO2012022730A1 Diazoxide for use in the treatment of amyotrophic lateral sclerosis (als) |
02/23/2012 | WO2012022487A1 Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor |
02/23/2012 | WO2012003554A3 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates |
02/23/2012 | WO2011143526A9 Topical peripheral neuro-affective (tpna) therapy |
02/23/2012 | WO2011136700A3 Agent exhibiting the properties of a cognitive function promoter (embodiments) |
02/23/2012 | WO2011135332A4 Nmn modulators for the treatment of neurodegenerative disorders |
02/23/2012 | WO2011130675A3 Dopaminergic neurons differentiated from pluripotent stem cells and uses of thereof |
02/23/2012 | WO2011126903A3 Multisubstituted aromatic compounds as inhibitors of thrombin |
02/23/2012 | WO2011119649A3 Pharmaceutical compositions containing berberine for treatment or prevention of weight gain and obesity associated with anti-psychotic drugs |
02/23/2012 | WO2011107881A3 Compounds, compositions, formulations and their uses in the treatment diseases related to copper retention or hepatic disorders |
02/23/2012 | WO2011106692A9 Methods of using (1s, 3s) -3-amino-4-difluoromethylenyl-1-cyclopentanoic acid |
02/23/2012 | WO2011097181A3 Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders |
02/23/2012 | US20120046441 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery |
02/23/2012 | US20120046368 Method for purifying 3,4-dihydroxyphenylglycol (dhpg) from plant products |
02/23/2012 | US20120046365 Method and Composition for Administering an NMDA Receptor Antagonist to a Subject |
02/23/2012 | US20120046352 Controlled cannabis decarboxylation |